FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Retinopathy market is projected to continue to grow at a substantial rate for years to come.

Canada, an innovative health services company transforming the delivery of evidence-based care, today shared the latest enhancements to mental health support available on the Kii Platform. The ...

Kraken, one of the world's most trusted and longest-standing cryptocurrency platforms with more than 15 million global clients, now offers US securities to US-residing clients. By expanding their ...

ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the“Company”) recently announced U.S. FDA approval of its innovative yield enhancement production process. This innovative process has demonstrated an ...

Former House Speaker Nancy Pelosi said back in 2022 the Senate would soon vote on a bill banning members of Congress from trading individual stocks. More than two years later, Pelosi is no longer ...

When it comes to shares of Tempus AI (NASDAQ: TEM), many may feel like they're standing on a dock watching the stock sail off ...

CHICAGO, April 29, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication ...

CHICAGO, April 28, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced Tempus Loop ...

The validation study recently published in the Journal of Molecular Diagnostics Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine with a market capitalization of $9.15 billion, announced the launch of Tempus Loop, a new platform designed to ...